Subscribe to Supplier

Subscribe to Supplier

.
Bachem to exhibit at CPHI Barcelona 2023

Research & Development News Releases

Find the latest News in Research & Development

Page 22 of 106
Bachem to exhibit at CPHI Barcelona 2023
Bachem to exhibit at CPHI Barcelona 2023 Learn More >
enGenes announce attendance to Recombinant Protein Production (RPP) conference in Girona, Spain
enGenes announce attendance to Recombinant Protein Production (RPP) conference in Girona, Spain Learn More >
CBDepot and CB21 Pharma webinar on Czech-sourced cGMP cannabinoid APIs
CBDepot and CB21 Pharma webinar on Czech-sourced cGMP cannabinoid APIs Learn More >
Evercyte contributing to inaugural MOVE Symposium
Evercyte contributing to inaugural MOVE Symposium Learn More >
enGenes Biotech to make CPHI debut in Barcelona
enGenes Biotech to make CPHI debut in Barcelona Learn More >
Biosynth is pleased to announce the acquisition of Pepceuticals, a UK producer of synthetic peptides
Biosynth is pleased to announce the acquisition of Pepceuticals, a UK producer of synthetic peptides Learn More >
CBDepot and CB21 Pharma exhibit Czech-made EU GMP cannabis-derived APIs at CPHI Barcelona
CBDepot and CB21 Pharma exhibit Czech-made EU GMP cannabis-derived APIs at CPHI Barcelona Learn More >
Bioassay to review potency testing choices at Basle Festival of Biologics
Bioassay to review potency testing choices at Basle Festival of Biologics Learn More >
Biosynth showcasing antibody, epitope mapping and peptide capabilities at Festival of Biologics Basel 2023
Biosynth showcasing antibody, epitope mapping and peptide capabilities at Festival of Biologics Basel 2023 Learn More >
CB21 Pharma extends EU GMP Certification for cannabinoid active pharma ingredients
CB21 Pharma extends EU GMP Certification for cannabinoid active pharma ingredients Learn More >
Gasporox demonstrating non-destructive CCIT for parenterals at A3P International Congress Biarritz
Gasporox demonstrating non-destructive CCIT for parenterals at A3P International Congress Biarritz Learn More >
Orano Med Teams Up with Biosynth to Develop Their Next Targeting Vector for Radioligand Therapies
Orano Med Teams Up with Biosynth to Develop Their Next Targeting Vector for Radioligand Therapies Learn More >
Page 22 of 106